Literature DB >> 8395622

Viruses and Hodgkin's disease.

R F Jarrett1.   

Abstract

Hodgkin's disease (HD) is a heterogeneous condition with distinct histological and epidemiological subgroups. Recent data provide evidence that the Epstein-Barr virus (EBV) is associated with a significant proportion of cases. Clonal EBV genomes have been detected in affected tissues and EBV has been localised to RS cells. The significance of these findings is reinforced by the detection of the EBV latent gene product LMP-1, which has known transforming potential, within RS cells in EBV-associated cases. The age distribution of EBV-associated cases is non-random. Paediatric cases, particularly those aged < 10 years, are likely to be EBV-associated as are older adult cases. In contrast, a smaller proportion of young adult cases is EBV-associated, and nodular sclerosis HD cases within this age group are positive infrequently. The results of our studies provide support for the hypothesis that HD has multiple aetiologies but do not support the polio model. The epidemiological evidence suggesting that HD may have an infectious aetiology is strongest for the young adult age group. EBV was suggested as a candidate virus however it is in these cases that there is least evidence for involvement of EBV. It would seem plausible that another virus, possibly another common childhood infectious agent, is responsible for the incidence peak seen in this age group in developed countries.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395622

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  2 in total

1.  Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes.

Authors:  G M Taylor; D A Gokhale; D Crowther; P J Woll; M Harris; D Ryder; M Ayres; J A Radford
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

2.  A case-control study of Hodgkin's disease and pregnancy.

Authors:  M Zwitter; M P Zakelj; K Kosmelj
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.